Treatment options for leishmaniasis
Swetalina Pradhan, Robert A. Schwartz, Amey Patil, Stephan Grabbe, Mohamad Goldust
Abstract
Leishmaniasis is broadly classified into three types: cutaneous, mucocutaneous and visceral. The visceral form is most dangerous and can result in death. Although leishmaniasis is an ancient disease, its treatment is still challenging. Several drugs, differing in their cost, toxicity, treatment duration and emergence of drug resistance, are used for different types of leishmaniasis. To overcome these limitations, the search for newer drugs and other treatments continues. In this article, we discuss conventional drugs, other treatments, including newer options such as immunotherapy and immunochemotherapy, and future prospects for leishmaniasis treatment.
Topics & Concepts
MedicineLeishmaniasisMucocutaneous zoneVisceral leishmaniasisDermatologyDrugIntensive care medicineDiseaseImmunotherapyImmunologyPharmacologyInternal medicineImmune systemResearch on Leishmaniasis StudiesTrypanosoma species research and implications